A groundbreaking new tool, FastGlioma, has been developed to detect residual cancerous tissue in brain tumors during surgery. This AI-powered tool uses stimulated Raman histology and artificial intelligence to analyze tissue samples in real-time, providing neurosurgeons with accurate and fast results. FastGlioma has been shown to outperform conventional methods, with a 3.8% tumor miss rate…
cancer on The Soothsayer / page 2
Researchers at the University of Iowa and University Medical Center Utrecht have made a significant breakthrough in cancer treatment by incorporating volumetric-modulated arc therapy (VMAT) delivery capabilities into the MR-linac. This innovation could improve plan quality and efficiency, reduce patient discomfort, and make MRI-guided treatments more accessible to patients. The team demonstrated that VMAT deliveries…
A team of researchers from the USA and India has developed a mathematical model to investigate the complex relationship between exercise, immune function, and cancer. The model reveals that increasing exercise intensity and duration leads to greater and sustained tumour suppression, offering valuable insights into how exercise can influence immune responses and potentially guide cancer…
Researchers at New York University have made a groundbreaking discovery that kidney cells can store information and recognize patterns in a similar way to neurons, challenging the long-held notion that memory is exclusive to the brain. The study, published in Nature Communications, found that kidney cells exhibit a “massed-space effect,” a feature of memory that…
Scientists have made a groundbreaking discovery in understanding the human brain’s unique genetic features, which could lead to new therapies for conditions such as Parkinson’s disease and schizophrenia. By comparing human and primate brain cells, researchers found that human dopamine neurons express more genes that boost the activity of damage-reducing antioxidants, allowing them to cope…
The article highlights six antisense oligonucleotide companies leading the way in this emerging field. These companies, including Ionis Pharmaceuticals, Isarna Therapeutics, Regulus Therapeutics, Sarepta Therapeutics, Secarna Pharmaceuticals, and Wave Life Sciences, are developing innovative treatments for various diseases. The global antisense oligonucleotides market is projected to grow significantly, driven by the ability of these treatments…
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in regulating gene expression. Several companies are advancing candidates relying on miRNAs in 2024, with potential applications in disease diagnosis and treatment. Companies such as aceRNA Technologies, ARTHEx Biotech, and Transcode Therapeutics are developing innovative miRNA-based therapeutics for various diseases, including cancer, cardiovascular…
Gene therapy has emerged as a transformative approach in modern medicine, offering a potential cure for a wide array of genetic disorders. By introducing, modifying, or repairing genetic material within a patient’s cells, gene therapy aims to rectify underlying genetic defects, thereby treating or preventing disease. The field has witnessed significant milestones, with several gene…
The biotech industry is witnessing a surge in the development of bispecific antibodies, a type of targeted therapy that can deliver two-in-one treatments to patients with cancer and other diseases. Several companies, including Adaptin Bio, Akeso, AP Biosciences, Candid Therapeutics, Summit Therapeutics, and Zenas BioPharma, are working on various bispecific antibody candidates, some of which…
Researchers from China and Spain have developed a nanoflake-based breath sensor that can detect lung cancer with unprecedented accuracy. The sensor, made from platinum-loaded nanoflakes, can detect isoprene levels in exhaled breath, a biomarker for lung cancer. The device has shown promising results in clinical trials, distinguishing between healthy individuals and lung cancer patients with…
